Shares of Curaleaf Holdings (CURLF) rose over 25% in the past week following the board’s approval of an $83 million share repurchase program, aimed at enhancing shareholder value. The program permits the repurchase of up to 34.4 million shares, approximately 5% of its outstanding float, to be executed over the next 12 months opportunistically in the open market.
In 2025, Curaleaf generated approximately $172 million in international revenues, representing a 63% year-over-year increase, although this segment accounted for only 14% of total revenues of $1.27 billion. While Curaleaf’s U.S. operations face significant challenges, including a persistent pricing environment and regulatory uncertainty, management remains optimistic about international expansion opportunities in markets like France and Spain.
Despite the positive international growth, competition from peers such as Green Thumb (GTBIF) and Tilray Brands (TLRY) puts pressure on Curaleaf. The company has seen recent revisions in earnings estimates, leading to a Zacks Rank #4 (Sell), indicating limited upside and elevated risks for investors in the near term.
